Condensed Statements of Consolidated Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net income	$ 157,337,000	$ 109,995,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of property	11,033,000	10,863,000
Amortization of intangibles	15,519,000	16,205,000
Provision for losses on accounts receivable	9,573,000	1,328,000
Amortization of stock options and appreciation rights	1,871,000	2,516,000
Other share-based compensation expense	4,001,000	3,268,000
Changes in operating assets and liabilities, net of acquisitions	(111,542,000)	(61,066,000)
Other, net	1,031,000	(1,845,000)
Net Cash provided by Operating Activities	88,823,000	81,264,000
Cash Flows from Investing Activities
Acquisition of businesses, net of cash acquired	(25,516,000)	(6,974,000)
Capital expenditures	(12,817,000)	(7,510,000)
Proceeds from property sales	128,000	442,000
Cash payments for loans on company-owned life insurance	0	14,835,000
Net Cash used in Investing Activities	(38,205,000)	(28,877,000)
Cash Flows from Financing Activities
Net borrowings under revolving credit facility	0	442,592,000
Long-term debt repayments	40,123,000	550,371,000
Interest rate swap settlement receipts (payments)	(2,684,000)	3,294,000
Payment of debt issuance costs	0	(1,794,000)
Purchases of treasury shares	(716,000)	(10,064,000)
Dividends paid	(26,259,000)	(25,465,000)
Acquisition holdback payments	1,510,000	1,070,000
Exercise of stock appreciation rights and options	127,000	116,000
Taxes paid for shares withheld for equity awards	(3,340,000)	(4,093,000)
Net Cash used in Financing Activities	(69,137,000)	(153,443,000)
Effect of Exchange Rate Changes on Cash	(417,000)	(1,846,000)
Decrease in Cash and Cash Equivalents	(18,936,000)	(102,902,000)
Cash and Cash Equivalents at Beginning of Period	184,474,000	257,745,000
Cash and Cash Equivalents at End of Period	$ 165,538,000	$ 154,843,000